C12N2750/10011 - CPC Classification Index

ClassID:

110471 ⎘

C12N2750/10011 - CPC Classification

Classification description:

ssDNA viruses; Details Circoviridae

Sub-classes:

C12N2750/10021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 68
C12N2750/10022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 127
C12N2750/10023 » Virus like particles [VLP] 26
C12N2750/10031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2750/10032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 1
C12N2750/10033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 5
C12N2750/10034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 223
C12N2750/10041 » Use of virus, viral particle or viral elements as a vector 3
C12N2750/10051 » Methods of production or purification of viral material 85
C12N2750/10061 » Methods of inactivation or attenuation 46
C12N2750/10071 » Demonstrated in vivo effect 33
C12N2750/10088 » For redistribution 0

Recent Application in this class:

20240024448

2024-01-25

M Hyo Multivalent Vaccine and Uses Thereof

20100189684

2010-07-29

Use of gp130 activators in diabetic neuropathy

20100092512

2010-04-15

Methods for preventing and ameiliorating porcine respiratory and reproductive syndrome virus-associated disease by immunizing against porcine ttv infection

20090269282

2009-10-29

Methods for treating, preventing and diagnosing procine ttv infection

20090169506

2009-07-02

USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY

20080103099

2008-05-01

Apoptin-associating protein

20080058267

2008-03-06

Apoptin-associating protein

20050058623

2005-03-17

Use of gp130 activators in diabetic neuropathy